Filter Results:
(2,727)
Show Results For
- All HBS Web
(5,346)
- People (18)
- News (1,647)
- Research (2,727)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,756)
Show Results For
- All HBS Web
(5,346)
- People (18)
- News (1,647)
- Research (2,727)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,756)
Sort by
- August 2013
- Case
Contempo Technologies, Inc. and Betty Sievers: A Clash of Interests in an Uncertain Time
By: Srikant M. Datar, Michael R. Jaff D.O. and Caitlin N. Bowler
In an era of rapidly evolving systems of health care delivery, the impact on patients, physicians, hospitals, medical device manufacturers and small business owners are often conflicting. This case highlights these conflicts and stressors from all perspectives,... View Details
Datar, Srikant M., Michael R. Jaff D.O., and Caitlin N. Bowler. "Contempo Technologies, Inc. and Betty Sievers: A Clash of Interests in an Uncertain Time." Harvard Business School Case 114-009, August 2013.
- January 2019 (Revised February 2024)
- Teaching Note
Hubble Contact Lenses: Data Driven Direct-to-Consumer Marketing
By: Ayelet Israeli
Teaching Note for HBS No. 519-011. As its Series A extension round approaches, the founders of Hubble, a subscription-based, social-media fueled, direct-to-consumer (DTC) brand of contact lenses, are reflecting on the marketing strategies that have taken them to a... View Details
Keywords: DTC; Direct To Consumer Marketing; Health Care; Mobile; Attribution; Experimentation; Experiments; Churn/retention; Customer Lifetime Value; Internet Marketing; Big Data; Analytics; A/B Testing; CRM; Advertising; Marketing; Marketing Channels; Marketing Strategy; Media; Brands and Branding; Marketing Communications; Digital Marketing; Acquisition; Growth and Development Strategy; Customer Focus and Relationships; Consumer Behavior; Social Media; E-commerce
- August 2012 (Revised January 2013)
- Case
Public Health Insurance Exchanges: The Massachusetts Experience
By: Regina Herzlinger and Jordan Bazinsky
The CEO of Tufts Health Plan, James Roosevelt, is wondering whether to offer insurance products on the Massachusetts Connector, the first U.S. exchange. He wonders if he should enter these uncharted waters at all. And, if yes, with a broad network or a narrow network... View Details
- August 2018 (Revised August 2019)
- Case
Oscar Health Insurance: What Lies Ahead for a Unicorn Insurance Entrant?
By: Leemore Dafny and Victoria Marone
Keywords: Oscar Insurance; Fintech; US Health Care; Affordable Care Act (ACA); Health Insurance Marketplaces; Insurer Competition; Provider Consolidation; Market Entry; Health Care and Treatment; Entrepreneurship; Market Entry and Exit; Negotiation; Growth Management; Health Industry; Health Industry; New York (state, US); New Jersey
Dafny, Leemore, and Victoria Marone. "Oscar Health Insurance: What Lies Ahead for a Unicorn Insurance Entrant?" Harvard Business School Case 319-025, August 2018. (Revised August 2019.)
- 29 Jun 2015
- HBS Case
Consumer-centered Health Care Depends on Accessible Medical Records
can be used in powerful ways, ideally leading to better patient care, lower health care costs and, ultimately, healthier patients. “Trust on the part of both the consumer and... View Details
- Article
The Business of Medicine in the Era of COVID-19
By: David M. Cutler, Sayeh Nikpay and Robert S. Huckman
This Viewpoint discusses the shifting landscape of health care financing, regulation, and delivery as a result of the coronavirus pandemic, and discusses regulatory and other changes that need to be in place if telehealth and physician practice and hospital mergers... View Details
Keywords: Health Care; COVID-19; Telemedicine; Business; Health Pandemics; Health Care and Treatment; Change; Competition
Cutler, David M., Sayeh Nikpay, and Robert S. Huckman. "The Business of Medicine in the Era of COVID-19." JAMA, the Journal of the American Medical Association 323, no. 20 (May 26, 2020): 2003–2004.
- March 2000 (Revised January 2001)
- Background Note
Customers in Health Care, The
By: Richard M.J. Bohmer
Reviews the current literature on the consumers of health care, primarily patients. Discusses their stated preferences, the sources of information they use in making their selections of plan and provider, and their behavior. View Details
Bohmer, Richard M.J. "Customers in Health Care, The." Harvard Business School Background Note 600-118, March 2000. (Revised January 2001.)
- Article
Health App Policy: International Comparison of Nine Countries' Approaches
By: Anna Essén, Ariel Dora Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens and David W. Bates
An abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilitate the identification of... View Details
Keywords: Digital Health; Apps; Health Care and Treatment; Internet and the Web; Policy; Global Range; Applications and Software
Essén, Anna, Ariel Dora Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens, and David W. Bates. "Health App Policy: International Comparison of Nine Countries' Approaches." npj Digital Medicine 5, no. 31 (2022).
- March 2021 (Revised December 2021)
- Supplement
Humana (B) — Strategy Execution
By: Regina E. Herzlinger and Ashley Ifeadike
After Humana debuted its new pillar strategy focused on driving integration across members’ health care experiences, feedback from investors in private conferences and other forums was positive but stressed the need for execution and faced several questions in order to... View Details
Keywords: Health Care; Health Care Operations; Health Insurance; Health Care and Treatment; Insurance; Operations; Strategy; Health Industry
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (B) — Strategy Execution." Harvard Business School Supplement 321-098, March 2021. (Revised December 2021.)
- May 21, 2020
- Editorial
Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?
By: Leemore S. Dafny and J. Michael McWilliams
Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details
Keywords: COVID-19; Primary Care; Health Pandemics; Health Care and Treatment; Financial Condition; Insurance
Dafny, Leemore S., and J. Michael McWilliams. "Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?" Health Affairs Blog (May 21, 2020).
- 08 Jun 2015
- Working Paper Summaries
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
- September 2023
- Article
The Health Costs of Dirty Energy: Evidence from the Capacity Market in Colombia
By: Achyuta Adhvaryu, Theresa Molina, Anant Nyshadham, Jorge Tamayo and Nicholas Torres
The health effects of “dirty” (fossil fuel driven) energy production are difficult to measure accurately due to the endogeneity of fuel choice. We exploit an electricity policy in Colombia that generates a price-based trigger for the use of thermal energy sources.... View Details
Adhvaryu, Achyuta, Theresa Molina, Anant Nyshadham, Jorge Tamayo, and Nicholas Torres. "The Health Costs of Dirty Energy: Evidence from the Capacity Market in Colombia." Art. 103116. Journal of Development Economics 164 (September 2023).
- June 10, 2021
- Article
Preparing Hospitals for the Next Pandemic
By: Regina E. Herzlinger and Barak D. Richman
The COVID-19 epidemic response has shown that the U.S. is blessed with heroic physicians and other health care providers, researchers, and facilities. But it has also revealed a health care system that was woefully unprepared for the surge of pandemic patients. In the... View Details
Keywords: Hospital; Hospital Management; Hospitals—administration; Health Care; Health Care Industry; Health Care Investment; Health Care Operations; Health Pandemics; Health Care and Treatment; Operations; Performance Improvement; Investment; Health Industry; United States
Herzlinger, Regina E., and Barak D. Richman. "Preparing Hospitals for the Next Pandemic." Harvard Business Review Digital Articles (June 10, 2021).
- 2014
- Chapter
Reframing Hierarchical Interactions as Negotiations to Promote Change in Health Care Systems
By: Patricia Satterstrom, Jeff Polzer and Robert Wei
Satterstrom, Patricia, Jeff Polzer, and Robert Wei. "Reframing Hierarchical Interactions as Negotiations to Promote Change in Health Care Systems." Chap. 18 in Handbook of Conflict Management Research, edited by Oluremi B. Ayoko, Neal M. Ashkansy, and Karen Jehn, 291–307. Edward Elgar Publishing, 2014.
- 2009
- Working Paper
Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings
By: Joseph Rhatigan, Sachin H Jain, Joia S. Mukherjee and Michael E. Porter
The care delivery value chain is a framework that can help conceptualize the organization and structure of care delivery for medical conditions. We apply this framework to HIV/AIDS care in resource-limited settings. Several conclusions arise than can help inform... View Details
Keywords: Customer Value and Value Chain; Framework; Health Care and Treatment; Health Disorders; Service Delivery
Rhatigan, Joseph, Sachin H Jain, Joia S. Mukherjee, and Michael E. Porter. "Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings." Harvard Business School Working Paper, No. 09-093, February 2009.
- 05 Feb 2009
- Research & Ideas
In Praise of Marketing
messages to those who are not interested in their products or services. It is now possible for chief marketing officers to calculate return on marketing investment and to... View Details
- December 2020
- Other Article
Digital Health Care: Empowering Consumers: Q&A with Professor Regina Herzlinger
Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration, has been studying the health care sector for nearly half a century. In that time, she has seen significant innovation in the field—and she has also seen the powerful sway of the status quo,... View Details
Keywords: Digital Health; Telemedicine; Wearable Sensors; Health Care and Treatment; Technological Innovation; Health Industry
Herzlinger, Regina E. "Digital Health Care: Empowering Consumers: Q&A with Professor Regina Herzlinger." HBS Alumni Bulletin (December 2020).
- Article
Affording to Wait: Medicare Initiation and the Use of Health Care
By: Guy David, Philip Saynisch, Victoria Acevado-Perez and Mark D. Neuman
Delays in receipt of necessary diagnostic and therapeutic medical procedures related to the timing of Medicare initiation at age 65 years have potentially broad welfare implications. We use 2005–2007 data from Florida and North Carolina to estimate the effect of... View Details
Keywords: Medicare; Behavior; Insurance; Health Care and Treatment; Health Industry; Health Industry; Health Industry; North Carolina; Florida
David, Guy, Philip Saynisch, Victoria Acevado-Perez, and Mark D. Neuman. "Affording to Wait: Medicare Initiation and the Use of Health Care." Health Economics 21, no. 8 (August 2012): 1030–1036.
- Spring 2020
- Article
Establishing High Performing Teams: Lessons from Health Care
By: Michael Anne Kyle, Emma-Louise Aveling and Sara J. Singer
Effective teams can be significant drivers of innovations that enable broader quality improvements and efficiency gains across organizations. But despite the wealth of research and managerial expertise describing characteristics of effective teams, people and... View Details
Kyle, Michael Anne, Emma-Louise Aveling, and Sara J. Singer. "Establishing High Performing Teams: Lessons from Health Care." Special Issue on Disruption 2020. MIT Sloan Management Review 61, no. 3 (Spring 2020): 14–18.
- November 2013
- Case
GlaxoSmithKline in China (A)
By: John A. Quelch and Margaret L. Rodriguez
Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (A)." Harvard Business School Case 514-049, November 2013.